Delivery Order SPE2DB22D2206-SPE2DB26FDT48
Award Date 10/24/25
Potential Completion Date 11/17/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,564.32 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $2,789.25. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a hormone treatment used...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $7,564.32. The contract is scheduled for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $16,735.50 for Zoladex 10.8 mg implant syringes on August 8, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $3,719.00 and ultimate completion date of October 1, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $11,157.00 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of October 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 17, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $1,859.50 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.25 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of October 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the procurement was open to all qualified vendors. This delivery order is...